← back to search

Stephan Macher-Göppinger

Johannes Gutenberg University Mainz · DE
Area of research
Pulmonary and Respiratory Medicine · Molecular Biology
Research interest
Research interests include Renal cell carcinoma treatment, Cell death mechanisms and regulation, Renal and related cancers, and Phagocytosis and Immune Regulation.
h-index
10
citations
514
works
32
NIH funding
primary concept
email

Recent publications

Evaluation of Gas 6 as a Prognostic Marker in Papillary Renal Cell Carcinoma
Urologia Internationalis 2023cited by 0position: middledoi
Expression of Prostate-specific Membrane Antigen (PSMA) in Papillary Renal Cell Carcinoma - Overview and Report on a Large Multicenter Cohort
Journal of Cancer 2022cited by 13position: middledoi
cMET: a prognostic marker in papillary renal cell carcinoma?
Human Pathology 2022cited by 3position: middledoi
Pathological RANK signaling in B cells drives autoimmunity and chronic lymphocytic leukemia
The Journal of Experimental Medicine 2020cited by 20position: middledoi
Characterization of PD-1 and PD-L1 Expression in Papillary Renal Cell Carcinoma: Results of a Large Multicenter Study
Clinical Genitourinary Cancer 2020cited by 9position: middledoi
Myeloid cell–synthesized coagulation factor X dampens antitumor immunity
Science Immunology 2019cited by 137position: middledoi
The Novel X-Ray Visible Zein-Based Non-adhesive Precipitating Liquid Embolic HEIE1_2017: An Exploratory Study
CardioVascular and Interventional Radiology 2019cited by 3position: middledoi
Transcriptome 3′end organization by PCF11 links alternative polyadenylation to formation and neuronal differentiation of neuroblastoma
Nature Communications 2018cited by 106position: middledoi
High proliferation rate and TNM stage but not histomorphological subtype are independent prognostic markers for overall survival in papillary renal cell carcinoma
Human Pathology 2018cited by 45position: middledoi
PCF11 links alternative polyadenylation to formation and spontaneous regression of neuroblastoma
bioRxiv (Cold Spring Harbor Laboratory) 2018cited by 2position: middledoi
In vivo characterization of a new type of biodegradable starch microsphere for transarterial embolization
Journal of Biomaterials Applications 2017cited by 24position: lastdoi
ETHIBLOC_Reloaded: First <i>in-vivo</i> results of the re-designed zein-based fluid embolic agent
Cogent Medicine 2017cited by 2position: middledoi
The soluble Decoy Receptor 3 is regulated by a PI3K-dependent mechanism and promotes migration and invasion in renal cell carcinoma
Molecular Cancer 2013cited by 35position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Christof M. Sommer · Heidelberg University3 papers (2017–2019)Fédérico Marini · Johannes Gutenberg University Mainz3 papers (2018–2019)Dominik F. Vollherbst · McLaren Regional Medical Center3 papers (2017–2019)Philippe L. Pereira · Danube Private University3 papers (2017–2019)Hans‐Ulrich Kauczor · German Cancer Research Center3 papers (2017–2019)Surendra Tattikota · Johannes Gutenberg University Mainz2 papers (2018–2018)Karl J. Lackner · Johannes Gutenberg University Mainz2 papers (2018–2018)Denise Scherzinger · Johannes Gutenberg University Mainz2 papers (2018–2018)Mainul Hoque · Rutgers, The State University of New Jersey2 papers (2018–2018)Bin Tian · Central South University2 papers (2018–2018)Michal Levin · Johannes Gutenberg University Mainz2 papers (2018–2018)Michael Schaefer · Johannes Gutenberg University Mainz2 papers (2018–2018)Götz M. Richter · University Hospital Heidelberg2 papers (2017–2019)Sergey V. Tokalov · Johannes Gutenberg University Mainz2 papers (2018–2018)Harald Binder · SMART Reading2 papers (2018–2018)Ansgar Poetsch · Nanchang University2 papers (2018–2018)Thuy Duong · University Hospital Heidelberg2 papers (2017–2019)Frank Westermann · Heidelberg University2 papers (2018–2018)Anton Ogorodnikov · University of California, San Francisco2 papers (2018–2018)Sven Danckwardt · Bordeaux Population Health2 papers (2018–2018)